← REGULATORY CHANGES
FEDERAL REGISTER · NOTICEJanuary 3, 2024NOTICE — NO LEGAL EFFECT

Food and Drug Administration's Draft Report and Plan on Best Practices for Guidance; Availability

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSNOTICE — NO LEGAL EFFECT
EFFECTIVE—
COMMENTS CLOSEMar 4, 2024 · closed
APPLIES TO · SPEQ TAGNot tagged
Document type
Notice
Agency
Health and Human Services Department
Published
January 3, 2024
Comments close
March 4, 2024
Document number
2023-28872
Docket
FDA-2023-N-5653
ABSTRACT

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document entitled "Food and Drug Administration's Draft Report and Plan on Best Practices for Guidance." This draft report responds to the Consolidated Appropriations Act of 2023, which directs FDA to issue a report identifying best practices for the efficient prioritization, development, issuance, and use of guidance documents and a plan for implementation of such best practices. It also directs FDA to publish a draft report and plan no later than 1 year after enactment of the Consolidated Appropriations Act and to consult with stakeholders in developing the report and implementation plan.

Abstract as published in the Federal Register.

READ THE FULL DOCUMENT

The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.

View on federalregister.gov →

That is what FDA published. A free account files it on your watchlist and sends one weekly email with whatever lands next.

Create a free account